Please check your internet connection and try again.
# Folic Acid
## Overview
Folic acid (vitamin B9) is a water-soluble B vitamin essential for DNA synthesis, repair, and erythropoiesis. Synthetic folic acid has higher bioavailability than naturally occurring food folates.
## Primary Indications
* Treatment/prevention of folate-deficiency anemia.
* Prevention of neural tube defects (NTDs) in pregnancy.
* Reduction of hematologic/GI toxicity in patients on methotrexate therapy.
* Adjunctive therapy in psychiatric disorders (e.g., major depressive disorder).
## Adult Dosing
* **Folate-Deficiency Anemia:** 1 mg daily (range: 1–5 mg/day).
* **Pregnancy (NTD Prevention):** 400–800 mcg daily, starting at least 1 month before conception and continuing through the first trimester.
* **High-Risk Pregnancy (History of NTD):** 4–5 mg daily.
* **Methotrexate Supplementation:** 1–5 mg daily (non-MTX days) or 5 mg once weekly to reduce toxicity.
## Pediatric Dosing
* **Treatment of Deficiency:** 0.5–1 mg daily.
* **Maintenance:**
* Infants: 0.1 mg daily.
* Children 1–10 years: 0.2–0.3 mg daily.
* Children >11 years: 0.4 mg daily.
* **Note:** Dosing varies by institutional protocol for specific conditions (e.g., malabsorption syndromes).
## Dose Adjustments
* **Renal/Hepatic Impairment:** No standard dose reduction required.
* **Dialysis:** Patients on hemodialysis may require higher doses (e.g., 1–5 mg daily) due to dialysate losses.
## Contraindications
* Hypersensitivity to folic acid.
* **Crucial:** Do not use as monotherapy in undiagnosed megaloblastic anemia (e.g., pernicious anemia/B12 deficiency); it may mask vitamin B12 deficiency symptoms while allowing neurological damage to progress.
## Adverse Effects
Generally well-tolerated. Rare reports include:
* GI: Nausea, abdominal distension, flatulence.
* Dermatologic: Pruritus, rash, urticaria.
* Neurologic: Altered sleep patterns, irritability (at very high doses).
## Key Drug Interactions
* **Methotrexate:** Folic acid can reduce the therapeutic efficacy of methotrexate for rheumatoid arthritis or psoriasis; schedule appropriately.
* **Anticonvulsants (Phenytoin, Carbamazepine, Valproate):** Folic acid may decrease serum concentrations of these medications, potentially increasing seizure risk.
* **Sulfasalazine:** Inhibits intestinal absorption of folic acid.
## Monitoring
* **Efficacy:** Hemoglobin, hematocrit, and mean corpuscular volume (MCV).
* **Vitamin B12:** Always rule out B12 deficiency (serum B12, methylmalonic acid) prior to initiating high-dose folic acid.
## Clinical Pearls
* Folic acid is highly stable; however, it is light-sensitive and should be stored in light-resistant containers.
* Patients with MTHFR mutations may benefit from 5-methyltetrahydrofolate (L-methylfolate), though clinical evidence for superior outcomes over folic acid in general populations is debated.
* In the presence of B12 deficiency, folic acid will correct the anemia but will **not** prevent or reverse the irreversible neurological deficits associated with B12 deficiency.
***
**Disclaimer:** This information is for educational purposes only. Clinical protocols and safety information can change. Always verify current prescribing information, institutional guidelines, and patient-specific factors via an official drug database (e.g., Lexicomp, UpToDate) or the product package insert before prescribing or administering medication.